CHARLES SCHWAB INVESTMENT MANAGEMENT INC - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 1 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$34,188
-40.3%
13,2510.0%0.00%
Q2 2023$57,24413,2510.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
MASSMUTUAL TRUST CO FSB/ADV 4,824$13,7000.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders